Bringing the fundamentals into focus…
Back to ArriVent BioPharma, Inc.
How ArriVent BioPharma, Inc. stacks up
AVBP · against 480 other Healthcare companies of similar size
Profitability
15/ 100
Near the bottom of its peers.
Ranked #416 of 481 · scores higher than 13% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 10–19, including AVBP · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 91% of peers. Return on assets: -41.5% vs peer median 1.7%
- a lower return on invested capital: weaker than 90% of peers. Return on invested capital: -65.5% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = AVBP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AVBP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 455 reported | -65.5% | 2.5% | 8% | 33% | |
| Operating marginHigher is better · 451 reported | Not reported | 4.8% | — | — | 33% |
| Return on assetsHigher is better · 476 reported | -41.5% | 1.0% | 9% | 33% | |
| Return on equityHigher is better · 455 reported | -53.3% | 1.6% | 13% | Context only | |
| Gross marginHigher is better · 497 reported | 0.0% | 42.5% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around AVBP| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 411 | 1.1B USD | 16 | 50 | |
| 411 | 1.3B USD | 16 | 30 | |
| 411 | 650M USD | 16 | 48 | |
| 411 | 643M USD | 16 | 31 | |
| 416 | 642M USD | 15 | 46 | |
| 416 | 424M USD | 15 | 45 | |
| 418 | 11.6B TWD (≈$360M) | 14 | 45 | |
| 418 | 684M USD | 14 | ||
| 420 | 968M USD | 13 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score